Pfizer shares promising news on COVID vaccine for babies
Published
Pfizer says three child-sized doses of its COVID vaccine produced a strong immune response in kids ages six months to five years.
Full ArticlePublished
Pfizer says three child-sized doses of its COVID vaccine produced a strong immune response in kids ages six months to five years.
Full ArticleWatch VideoThree doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced..